Ardelyx (ARDX) News Today $3.56 -0.05 (-1.39%) Closing price 04:00 PM EasternExtended Trading$3.56 0.00 (-0.14%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARDX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period SG Americas Securities LLC Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX)SG Americas Securities LLC grew its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 203.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 166,343 shares of the biopharmaceutical company's sJune 20 at 3:27 AM | marketbeat.comArdelyx (NASDAQ:ARDX) vs. Clearside Biomedical (NASDAQ:CLSD) Head-To-Head AnalysisJune 20 at 3:27 AM | americanbankingnews.comInsider Buying: Ardelyx, Inc. (NASDAQ:ARDX) Director Buys 200,000 Shares of StockJune 19 at 7:26 AM | insidertrades.comArdelyx (NASDAQ:ARDX) Earns Buy Rating from Analysts at HC WainwrightJune 19 at 2:51 AM | americanbankingnews.comArdelyx, Inc. (NASDAQ:ARDX) Director David M. Mott Buys 200,000 SharesArdelyx, Inc. (NASDAQ:ARDX - Get Free Report) Director David M. Mott purchased 200,000 shares of the stock in a transaction dated Monday, June 16th. The shares were purchased at an average price of $3.63 per share, with a total value of $726,000.00. Following the completion of the transaction, the director now owns 2,896,871 shares of the company's stock, valued at approximately $10,515,641.73. This trade represents a 7.42% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.June 18 at 11:21 PM | marketbeat.comArdelyx Stockholders Approve Equity Plan AmendmentJune 18 at 6:29 PM | tipranks.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXJune 18 at 12:36 PM | globenewswire.comHC Wainwright Reiterates "Buy" Rating for Ardelyx (NASDAQ:ARDX)HC Wainwright restated a "buy" rating and set a $10.00 price objective on shares of Ardelyx in a research note on Wednesday.June 18 at 8:05 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXJune 17 at 10:00 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXJune 15, 2025 | globenewswire.com129,863 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Purchased by Harbor Capital Advisors Inc.Harbor Capital Advisors Inc. purchased a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm purchased 129,863 shares of the biopharmaceutical company's stock, valued at approximately $638,000. Harbor Capital AdJune 14, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXJune 12, 2025 | prnewswire.comArdelyx, Inc. (NASDAQ:ARDX) Director Acquires $738,000.00 in StockJune 12, 2025 | insidertrades.comCantor Fitzgerald Predicts Ardelyx FY2026 EarningsJune 11, 2025 | americanbankingnews.comCantor Fitzgerald Comments on Ardelyx FY2026 EarningsArdelyx, Inc. (NASDAQ:ARDX - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Ardelyx in a report released on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal expects that the biopharmaceutical company will earn ($0.05) per share fJune 10, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXJune 7, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ardelyx, Inc. - ARDXJune 6, 2025 | globenewswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 142,294 Shares of Ardelyx, Inc. (NASDAQ:ARDX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 32.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 578,256 shares of the biopharmaceutical company's stock after purchasiJune 6, 2025 | marketbeat.comArdelyx, Inc. (NASDAQ:ARDX) Receives Consensus Rating of "Moderate Buy" from BrokeragesArdelyx, Inc. (NASDAQ:ARDX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the ten research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and onJune 5, 2025 | marketbeat.comArdelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources OfficerJune 2, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXJune 2, 2025 | globenewswire.comMackenzie Financial Corp Buys 101,841 Shares of Ardelyx, Inc. (NASDAQ:ARDX)Mackenzie Financial Corp lifted its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 266.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 140,133 shares of the biopharmaceutical company's stock afJune 2, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXJune 1, 2025 | prnewswire.comArdelyx (NASDAQ:ARDX) Stock Price Down 7.1% - Time to Sell?Ardelyx (NASDAQ:ARDX) Trading Down 7.1% - Here's What HappenedMay 31, 2025 | marketbeat.comTwo Sigma Advisers LP Increases Position in Ardelyx, Inc. (NASDAQ:ARDX)Two Sigma Advisers LP grew its stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 206.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 593,700 shares of the biopharmaceutical company's stock after acquiring an additMay 29, 2025 | marketbeat.comVoloridge Investment Management LLC Has $4.54 Million Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX)Voloridge Investment Management LLC raised its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 24.6% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 895,748 shares of the biopharmaceutical company's stock after acquiring an additiMay 28, 2025 | marketbeat.comArdelyx, Inc. (NASDAQ:ARDX) Shares Purchased by Two Sigma Investments LPTwo Sigma Investments LP boosted its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,141,777 shares of the biopharmaceutical company's stMay 28, 2025 | marketbeat.com2 ‘Strong Buy’ Small-Cap Stocks With Blockbuster PotentialMay 26, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. ...May 26, 2025 | gurufocus.comDeutsche Bank AG Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX)Deutsche Bank AG increased its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 25.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 327,900 shares of the biopharmaceutical company's stockMay 26, 2025 | marketbeat.comArdelyx, Inc. (NASDAQ:ARDX) Insider Sells $26,197.68 in StockArdelyx, Inc. (NASDAQ:ARDX - Get Free Report) insider Laura A. Williams sold 6,421 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $4.08, for a total value of $26,197.68. Following the transaction, the insider now directly owns 402,583 shares in the company, valued at approximately $1,642,538.64. This trade represents a 1.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.May 25, 2025 | marketbeat.comMillennium Management LLC Trims Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX)Millennium Management LLC lowered its holdings in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 26.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,963,480 shares of the biopharmaceutical company's stock after selling 1,048,400 shares during the pMay 25, 2025 | marketbeat.comLaura A. Williams Sells 6,421 Shares of Ardelyx, Inc. (NASDAQ:ARDX) StockMay 24, 2025 | insidertrades.comInsider Selling: Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells 2,507 Shares of StockMay 23, 2025 | insidertrades.comTwo Seas Capital LP Makes New Investment in Ardelyx, Inc. (NASDAQ:ARDX)Two Seas Capital LP purchased a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,855,337 shares of the biopharmaceutical compMay 23, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 22, 2025 | globenewswire.comPoint72 Asset Management L.P. Purchases New Position in Ardelyx, Inc. (NASDAQ:ARDX)Point72 Asset Management L.P. purchased a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 1,333,810 shares of the biopharmaceuticalMay 22, 2025 | marketbeat.comArdelyx to Participate at the Jefferies Global Healthcare Conference 2025May 21, 2025 | globenewswire.comSherbrooke Park Advisers LLC Acquires Shares of 66,623 Ardelyx, Inc. (NASDAQ:ARDX)Sherbrooke Park Advisers LLC acquired a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 66,623 shares of the biopharmaceutical company's stock, valued at approximatelyMay 21, 2025 | marketbeat.comBNP Paribas Financial Markets Boosts Holdings in Ardelyx, Inc. (NASDAQ:ARDX)BNP Paribas Financial Markets boosted its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 54.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 280,269 shares of the biopharmaceutical company's stock afterMay 21, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 20, 2025 | prnewswire.comInsider Buying: Ardelyx, Inc. (NASDAQ:ARDX) Director Purchases 100,000 Shares of StockMay 20, 2025 | insidertrades.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. ...May 18, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 18, 2025 | globenewswire.comD. E. Shaw & Co. Inc. Buys 1,453,369 Shares of Ardelyx, Inc. (NASDAQ:ARDX)D. E. Shaw & Co. Inc. increased its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 9,499.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,468,668 shares ofMay 18, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Sells 130,801 Shares of Ardelyx, Inc. (NASDAQ:ARDX)The Manufacturers Life Insurance Company lessened its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 52.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 117,123 shares of the biopharmaceutical cMay 18, 2025 | marketbeat.comArdelyx (NASDAQ:ARDX) Reaches New 1-Year Low - Here's WhyArdelyx (NASDAQ:ARDX) Sets New 1-Year Low - Should You Sell?May 16, 2025 | marketbeat.comJanus Henderson Group PLC Buys 2,858,061 Shares of Ardelyx, Inc. (NASDAQ:ARDX)Janus Henderson Group PLC raised its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 13.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,387,941 shares of thMay 15, 2025 | marketbeat.comCubist Systematic Strategies LLC Takes $1.90 Million Position in Ardelyx, Inc. (NASDAQ:ARDX)Cubist Systematic Strategies LLC acquired a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 375,467 shares of the biopharmaceutical company's stock, valued at aMay 14, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 13, 2025 | globenewswire.com Get Ardelyx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter. Email Address ARDX Media Mentions By Week ARDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARDX News Sentiment▼0.820.68▲Average Medical News Sentiment ARDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARDX Articles This Week▼139▲ARDX Articles Average Week Get Ardelyx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTGX News Today SRRK News Today KYMR News Today VKTX News Today HCM News Today CRNX News Today CPRX News Today MOR News Today MTSR News Today ALVO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARDX) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersThe Pentagon just made a National Security move...This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.......Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardelyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ardelyx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARDX Stock Free ARDX Stock Alerts